Delaware Technical Innovation Program

KY Innovation offers comprehensive programs to help companies apply for, win and match federal Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) grants and contracts. The SBIR/STTR programs are known as America's Seed Fund for good reason. They provide a vital source of non-dilutive capital in the form of federal grants and contracts for promising technologies, while allowing innovators to maintain intellectual property and positioning them well to receive private follow on funding. KY Innovation can be a key partner in helping you compete. Innovators that receive SBIR or STTR awards can benefit from additional funding to bridge the gap between Phase I and Phase II, as well as to speed up the commercialization process. The Kentucky SBIR/STTR Matching Funds Award Program is a non-dilutive, reimbursable grant, awarded on a competitive basis. The grant will match up to $100,000 for a Phase I project, and up to $150,000 for a phase two project. Applicants must be recipients of a SBIR/STTR award, a for-profit company, and based in, or willing to re-locate to, Kentucky.

This notice of funding opportunity (NOFO) invites applications designed to examine the efficacy and clinical effectiveness of multimodality digital health technology approaches to the remote management of diabetes.

REDC offers grants of up to $5,000 for qualifying for-profit New Hampshire businesses with five or fewer employees to purchase equipment or machinery. Grant funding is limited and not guaranteed.

Are you a small business or commercial property owner in the unincorporated areas of Clark County, NV Commission District A? This grant program offers up to $25,000 to help you improve your property and strengthen your business presence. Eligible Improvements: -Tenant improvements -Building façade renovations -Installation or renovation of on-premise signs -Beautification of shared commercial areas

This notice of funding opportunity (NOFO) will support research towards understanding and mitigating the deleterious effects of acute exposure to Ultra-Potent Synthetic (UPS) opioids (e.g., fentanyl, carfentanil, nitazenes) and their combinations (fentanyl and xylazine). This NOFO will also support research on the persistent and/or delayed pathophysiological effects after acute exposure to such agents.